• 1983 Citations
  • 20 Scopus h-Index
19942019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1994 2019

  • 1983 Citations
  • 20 Scopus h-Index
  • 66 Article
  • 2 Chapter
  • 1 Comment/debate
2019
1 Citation (Scopus)

Oncologists' Attitudes and Practice of Addressing Diet, Physical Activity, and Weight Management With Patients With Cancer: Findings of an ASCO Survey of the Oncology Workforce

Ligibel, J. A., Jones, L. W., Brewster, A. M., Clinton, S. K., Korde, L. A., Oeffinger, K. C., Bender, C. M., Tan, W., Merrill, J. K., Katta, S. & Alfano, C. M., Jun 1 2019, In : Journal of oncology practice. 15, 6, p. e520-e528

Research output: Contribution to journalArticle

Exercise
Diet
Weights and Measures
Neoplasms
Referral and Consultation

Phase II trial of eribulin in patients with metastatic hormone refractory prostate cancer: A trial of the ECOG-ACRIN cancer research group (E5805)

Stein, M. N., Chen, Y. H., Carducci, M. A., Hudes, G. R., Lerma, P. M., Tan, W., Dalune, R., Rowland, K. M., Kuzel, T. M. & Dipaola, R. S., Jan 1 2019, In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

eribulin
Prostatic Neoplasms
Hormones
Drug Therapy
Research

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

Kumar, V., Ailawadhi, S., Bojanini, L., Mehta, A., Biswas, S., Sher, T., Roy, V., Vishnu, P., Marin-Acevedo, J., Alegria, V. R., Paulus, A., Aulakh, S., Iqbal, M., Manochakian, R., Tan, W., Chanan-Khan, A. & Ailawadhi, M., Oct 1 2019, In : Blood cancer journal. 9, 10, 75.

Research output: Contribution to journalArticle

Open Access
Second Primary Neoplasms
B-Cell Chronic Lymphocytic Leukemia
Survivors
Incidence
Survival Rate
2018
11 Citations (Scopus)

A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone

Wang, L., Dehm, S. M., Hillman, D. W., Sicotte, H., Tan, W., Gormley, M., Bhargava, V., Jimenez, R. E., Xie, F., Yin, P., Qin, S., Quevedo, F., Costello, B., Pitot, H. C., Ho, T. H., Bryce, A. H., Ye, Z., Li, Y., Eiken, P., Vedell, P. T. & 16 others, Barman, P., McMenomy, B. P., Atwell, T. D., Carlson, R. E., Ellingson, M., Eckloff, B. W., Qin, R., Ou, F., Hart, S., Huang, H., Jen, J., Wieben, E. D., Kalari, K. R., Weinshilboum, R. M., Wang, L. & Kohli, M., Feb 1 2018, In : Annals of Oncology. 29, 2, p. 352-360 9 p.

Research output: Contribution to journalArticle

Wnt Signaling Pathway
Prednisone
Prostatic Neoplasms
Cell Cycle
Cell Proliferation
2 Citations (Scopus)

Best Practices for Physician-Scientist Training Programs: Recommendations from the Alliance for Academic Internal Medicine

Blanchard, M., Burton, M. C., Geraci, M. W., Madaio, M. P., Marsh, J. D., Proweller, A., Rockey, D. C., Salata, R. A., Tan, W., Williams, C. S., Zaidi, M. & Todd, R. F., May 1 2018, In : American Journal of Medicine. 131, 5, p. 578-584 7 p.

Research output: Contribution to journalComment/debate

Internal Medicine
Practice Guidelines
Physicians
Education
2 Citations (Scopus)

Breast cancer metastasis to the bladder: A literature review

Kase, A. M., Menke, D. & Tan, W., Jan 1 2018, In : BMJ Case Reports. 2018, bcr-2017-222031.

Research output: Contribution to journalArticle

Urinary Bladder
Breast Neoplasms
Neoplasm Metastasis
Physicians
Biopsy
1 Citation (Scopus)

Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

Norton, N., Fox, N., McCarl, C. A., Tenner, K. S., Ballman, K., Erskine, C. L., Necela, B. M., Northfelt, D. W., Tan, W., Calfa, C., Pegram, M., Colon-Otero, G., Perez, E. A., Clynes, R. & Knutson, K. L., Jun 14 2018, In : Breast Cancer Research. 20, 1, 52.

Research output: Contribution to journalArticle

Immunity
Breast Neoplasms
Recurrence
Antibodies
Disease-Free Survival

High p95HER2/HER2 ratio associated with poor outcome in trastuzumab-treated HER2-positive metastatic breast cancer ncctg N0337 and NCCTG 98-32-52 (Alliance)

Chumsri, S., Sperinde, J., Liu, H., Gligorov, J., Spano, J. P., Antoine, M., Moreno Aspitia, A., Tan, W., Winslow, J., Petropoulos, C. J., Chenna, A., Bates, M., Weidler, J. M., Huang, W., Dueck, A. & Perez, E. A., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3053-3058 6 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Breast Neoplasms
Research Design
Therapeutics
Biomarkers

Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma

Niazi, S., Frank, R. D., Sharma, M., Roy, V., Ames, S., Rummans, T., Spaulding, A., Sher, T., Ailawadhi, M., Bhatia, K., Ahmed, S., Tan, W., Chanan Khan, A. A. & Ailawadhi, S., May 22 2018, In : Blood advances. 2, 10, p. 1120-1128 9 p.

Research output: Contribution to journalArticle

Patient Acceptance of Health Care
Multiple Myeloma
Health Care Costs
Psychiatry
Comorbidity
1 Citation (Scopus)

N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial

Tan, W. W., Hillman, D. W., Salim, M., Northfelt, D. W., Anderson, D. M., Stella, P. J., Niedringhaus, R., Bernath, A. M., Gamini, S. S., Palmieri, F. & Perez, E. A., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, 10, 1 p.

Research output: Contribution to journalArticle

irinotecan
docetaxel
Manuscripts
Organized Financing
Breast Neoplasms
8 Citations (Scopus)

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

for the MASCC Bone Study Group, Jan 1 2018, (Accepted/In press) In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Osteonecrosis
Jaw
Bone and Bones
Jaw Neoplasms
Bone Neoplasms
4 Citations (Scopus)

Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

Kohli, M., Li, J., Du, M., Hillman, D. W., Dehm, S. M., Tan, W., Carlson, R., Campion, M. B., Wang, L., Wang, L. M., Zhang, H., Zhang, P., Kilari, D., Huang, C. C. & Wang, L., Jun 1 2018, (Accepted/In press) In : Prostate Cancer and Prostatic Diseases. p. 1-8 8 p.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Castration
Androgen Receptors
Plasma Cells
Prostatic Neoplasms

Rare paraneoplastic dermatomyositis secondary to high-grade bladder cancer

Kase, A. M., Swaika, A., Geiger, X. J. & Tan, W., Mar 1 2018, In : Journal of Community and Supportive Oncology. 16, 2, p. e97-e99

Research output: Contribution to journalArticle

Dermatomyositis
Urinary Bladder Neoplasms
3 Citations (Scopus)

Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer

Giridhar, K., Sanhueza, C., Hillman, D. W., Alkhateeb, H., Carlson, R., Tan, W., Costello, B., Quevedo, F., Pagliaro, L. & Kohli, M., Jun 1 2018, (Accepted/In press) In : Prostate Cancer and Prostatic Diseases. p. 1-7 7 p.

Research output: Contribution to journalArticle

Chromogranin A
Castration
Circulating Neoplastic Cells
Prostatic Neoplasms
Serum

UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer

Campone, M., Lacroix-Triki, M., Roca, L., Spielmann, M., Wildiers, H., Cottu, P., Kerbrat, P., Levy, C., Desmoulins, I., Bachelot, T., Tan, W., Eymard, J. C., Uwer, L., Duhoux, F. P., Verhoeven, D., Jaubert, D., Coeffic, D., Orfeuvre, H., Canon, J. L., Asselain, B. & 3 others, Martin, A. L., Lemonnier, J. & Roché, H., Nov 1 2018, In : European Journal of Cancer. 103, p. 184-194 11 p.

Research output: Contribution to journalArticle

docetaxel
Breast Neoplasms
Disease-Free Survival
Triple Negative Breast Neoplasms
Confidence Intervals
2017
34 Citations (Scopus)

Androgen receptor variant AR-V9 is coexpressed with AR-V7 in prostate cancer metastases and predicts abiraterone resistance

Kohli, M., Ho, Y., Hillman, D. W., Van Etten, J. L., Henzler, C., Yang, R., Sperger, J. M., Li, Y., Tseng, E., Hon, T., Clark, T., Tan, W., Carlson, R. E., Wang, L., Sicotte, H., Ho, T. H., Jimenez, R. E., Huang, H., Vedell, P. T., Eckloff, B. W. & 9 others, Quevedo, J. F., Pitot, H. C., Costello, B., Jen, J., Wieben, E. D., Silverstein, K. A. T., Lang, J. M., Wang, L. M. & Dehm, S. M., Aug 15 2017, In : Clinical Cancer Research. 23, 16, p. 4704-4715 12 p.

Research output: Contribution to journalArticle

Androgen Receptors
Prostatic Neoplasms
Neoplasm Metastasis
Castration
abiraterone
16 Citations (Scopus)

Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes

Ho, T. H., Serie, D. J., Parasramka, M., Cheville, J. C., Bot, B. M., Tan, W., Wang, L. M., Joseph, R. W., Hilton, T., Leibovich, B. C., Parker, A. & Eckel-Passow, J. E., 2017, In : Annals of Oncology. 28, 3, p. 604-610 7 p.

Research output: Contribution to journalArticle

Gene Expression Profiling
Renal Cell Carcinoma
Extracellular Matrix
Up-Regulation
Neoplasm Metastasis
4 Citations (Scopus)

Personalized chemotherapy selection for breast cancer using gene expression profiles

Yu, K., Sang, Q. X. A., Lung, P. Y., Tan, W., Lively, T., Sheffield, C., Bou-Dargham, M. J., Liu, J. S. & Zhang, J., Mar 3 2017, In : Scientific Reports. 7, 43294.

Research output: Contribution to journalArticle

Neoplasm Genes
Transcriptome
Breast Neoplasms
Drug Therapy
Anthracyclines
2016
132 Citations (Scopus)

Active surveillance for the management of localized prostate cancer (Cancer Care Ontario guideline): American society of clinical oncology clinical practice guideline endorsement

Chen, R. C., Bryan Rumble, R., Andrew Loblaw, D., Finelli, A., Ehdaie, B., Cooperberg, M. R., Morgan, S. C., Tyldesley, S., Haluschak, J. J., Tan, W., Justman, S. & Jain, S., Jun 20 2016, In : Journal of Clinical Oncology. 34, 18, p. 2182-2190 9 p.

Research output: Contribution to journalArticle

Medical Oncology
Ontario
Practice Guidelines
Prostatic Neoplasms
Guidelines
12 Citations (Scopus)

Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer

Hart, S., Ellingson, M. S., Schahl, K., Vedell, P. T., Carlson, R. E., Sinnwell, J. P., Barman, P., Sicotte, H., Eckel-Passow, J. E., Wang, L., Kalari, K. R., Qin, R., Kruisselbrink, T. M., Jimenez, R. E., Bryce, A. H., Tan, W., Weinshilboum, R. M., Wang, L. M. & Kohli, M., 2016, In : BMJ Open. 6, 4, e010332.

Research output: Contribution to journalArticle

Exome
Prostatic Neoplasms
Mutation
Time and Motion Studies
Neoplasm Genes
24 Citations (Scopus)

Improved survival of HER2+ breast cancer patients treated with trastuzumab and chemotherapy is associated with host antibody immunity against the HER2 intracellular domain

Knutson, K. L., Clynes, R., Shreeder, B., Yeramian, P., Kemp, K. P., Ballman, K., Tenner, K. S., Erskine, C. L., Norton, N., Northfelt, D. W., Tan, W., Calfa, C., Pegram, M., Mittendorf, E. A. & Perez, E. A., Jul 1 2016, In : Cancer Research. 76, 13, p. 3702-3710 9 p.

Research output: Contribution to journalArticle

Immunity
Breast Neoplasms
Drug Therapy
Survival
Antibodies
16 Citations (Scopus)

Phase i Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

Tan, W., Allred, J. B., Moreno Aspitia, A., Northfelt, D. W., Ingle, J. N., Goetz, M. P. & Perez, E. A., Apr 1 2016, In : Clinical Breast Cancer. 16, 2, p. 82-86 5 p.

Research output: Contribution to journalArticle

letrozole
Breast Neoplasms
Histone Deacetylase Inhibitors
Triple Negative Breast Neoplasms
Maximum Tolerated Dose
379 Citations (Scopus)

Safety and efficacy of durvalumab (MEDI4736), an anti-programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer

Massard, C., Gordon, M. S., Sharma, S., Rafii, S., Wainberg, Z. A., Luke, J., Curiel, T. J., Colon-Otero, G., Hamid, O., Sanborn, R. E., O'Donnell, P. H., Drakaki, A., Tan, W., Kurland, J. F., Rebelatto, M. C., Jin, X., Blake-Haskins, J. A., Gupta, A. & Segal, N. H., Sep 10 2016, In : Journal of Clinical Oncology. 34, 26, p. 3119-3125 7 p.

Research output: Contribution to journalArticle

Urinary Bladder Neoplasms
Cell Death
Ligands
Safety
CD274 Antigen
2015
219 Citations (Scopus)

Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer

Huang, X., Yuan, T., Liang, M., Du, M., Xia, S., Dittmar, R., Wang, D., See, W., Costello, B., Quevedo, F., Tan, W., Nandy, D., Bevan, G. H., Longenbach, S., Sun, Z. D., Lu, Y., Wang, T., Thibodeau, S. N., Boardman, L. A., Kohli, M. & 1 others, Wang, L., Jan 1 2015, In : European Urology. 67, 1, p. 33-41 9 p.

Research output: Contribution to journalArticle

Castration
MicroRNAs
Prostatic Neoplasms
Survival
RNA Sequence Analysis

Kidney and Ureteral Carcinoma

Wong, W. W., Peterson, J. L., Tan, W., Haddock, M., Parker, A., Wehle, M. J. & Hutchinson, R. C., Jan 1 2015, Clinical Radiation Oncology. Elsevier Inc., p. 1139-1159.e5

Research output: Chapter in Book/Report/Conference proceedingChapter

Carcinoma
Kidney
12 Citations (Scopus)

The Estrogen Pathway: Estrogen Receptor-α, Progesterone Receptor, and Estrogen Receptor-β Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens

Tan, W., Boorjian, S., Advani, P., Farmer, S., Lohse, C., Cheville, J., Kwon, E. D. & Leibovich, B., Oct 1 2015, In : Clinical Genitourinary Cancer. 13, 5, p. 476-484 9 p.

Research output: Contribution to journalArticle

Cystectomy
Progesterone Receptors
Estrogen Receptors
Estrogens
Carcinoma
2014
18 Citations (Scopus)

Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC)

Gupta, E., Guthrie, T. & Tan, W., Jul 25 2014, In : BMC Urology. 14, 1, 55.

Research output: Contribution to journalArticle

Castration
Androgen Receptors
Prostatic Neoplasms
Androgens
Steroid 17-alpha-Hydroxylase

Editorial comment

Tan, W., Jan 2014, In : Urology. 83, 1, p. 165 1 p.

Research output: Contribution to journalArticle

Penile Neoplasms
Antibodies, Monoclonal, Humanized
Epidermal Growth Factor Receptor
Antineoplastic Agents
Squamous Cell Carcinoma
10 Citations (Scopus)

Integrated smoking cessation and binge drinking intervention for young adults: A pilot efficacy trial

Ames, S. C., Pokorny, S. B., Schroeder, D. R., Tan, W. & Werch, C. E., May 2014, In : Addictive Behaviors. 39, 5, p. 848-853 6 p.

Research output: Contribution to journalArticle

Binge Drinking
Smoking Cessation
Tobacco Products
Young Adult
Tobacco
2013
45 Citations (Scopus)

A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer

Pili, R., Qin, R., Flynn, P. J., Picus, J., Millward, M., Ho, W. M., Pitot, H. C., Tan, W., Miles, K. M., Erlichman, C. & Vaishampayan, U., Dec 2013, In : Clinical Genitourinary Cancer. 11, 4, p. 477-483 7 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor
Protein-Tyrosine Kinases
Safety
Neoplasms
Carcinoma
1 Citation (Scopus)

Ataxia in a patient with urothelial carcinoma: Pathologic confirmation, recovery, and improved survival

Gardner, F. P. & Tan, W., Jul 2013, In : Clinical Advances in Hematology and Oncology. 11, 7, p. 465-467 3 p.

Research output: Contribution to journalArticle

Ataxia
Carcinoma
Survival
3 Citations (Scopus)

Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrence

Tan, W., Heckman, M. G., Vishnu, P., Crook, J., Younkin, L. H., Covil, E. G., Ferman, T. J., Graff Radford, N. R., Younkin, S. G., Smallridge, R. C., Wehle, M. J. & Buskirk, S. J., Jan 2013, In : Urology. 81, 1, p. 150-154 5 p.

Research output: Contribution to journalArticle

Leuprolide
Amyloid
Prostatic Neoplasms
Recurrence
Peptides
8 Citations (Scopus)
Aromatase Inhibitors
Breast Neoplasms
Neoplasms
Disease-Free Survival
Therapeutics

Reply

Tan, W., Jan 2013, In : Urology. 81, 1, p. 154 1 p.

Research output: Contribution to journalArticle

96 Citations (Scopus)

Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma

Von Roemeling, C. A., Marlow, L. A., Wei, J. J., Cooper, S. J., Caulfield, T., Wu, K., Tan, W., Tun, H. W. & Copland, J. A. III., May 1 2013, In : Clinical Cancer Research. 19, 9, p. 2368-2380 13 p.

Research output: Contribution to journalArticle

Stearoyl-CoA Desaturase
Renal Cell Carcinoma
Therapeutics
Cell Survival
Growth
2012

Papules of unknown aetiology

Andhavarapu, S. & Tan, W., Sep 7 2012, In : New Zealand Medical Journal. 125, 1361, p. 102-104 3 p.

Research output: Contribution to journalArticle

Dermatomycoses
Ascomycota
Myelodysplastic Syndromes
Stem Cell Transplantation
Graft vs Host Disease
6 Citations (Scopus)

Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: A north central cancer treatment group trial

Tan, W., Allred, J. B., Salim, M., Flynn, P., Fishkin, P. A. S., Stella, P. J., Wiesenfeld, M., Bernath, A. M., Fitch, T. R. & Perez, E. A., 2012, In : Clinical Breast Cancer. 12, 2, p. 81-86 6 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Neoplasms
Confidence Intervals
Therapeutics
Disease-Free Survival
2011
13 Citations (Scopus)

A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer

Ames, S. C., Tan, W., Ames, G. E., Stone, R. L., Rizzo, T. D., Crook, J., Williams, C. R., Werch, C. E., Clark, M. M. & Rummans, T. A., Apr 2011, In : Psycho-Oncology. 20, 4, p. 435-440 6 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Quality of Life
Recurrence
Anxiety
Therapeutics
30 Citations (Scopus)

Current therapeutic strategies for invasive and metastatic bladder cancer

Vishnu, P., Mathew, J. & Tan, W., 2011, In : OncoTargets and Therapy. 4, p. 97-113 17 p.

Research output: Contribution to journalArticle

Urinary Bladder Neoplasms
Combination Drug Therapy
Neoplasms
Therapeutics
Angiogenesis Inhibitors

Kidney and Ureteral Carcinoma

Wong, W. W., Buskirk, S. J., Tan, W., Peterson, J. L., Haddock, M., Parker, A. & Wehle, M. J., Oct 27 2011, Clinical Radiation Oncology: Third Edition. Elsevier Inc., p. 1145-1165 21 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Carcinoma
Kidney
5 Citations (Scopus)

Quality of life of patients undergoing surgical treatment for newly-diagnosed, clinically localized renal cell carcinoma

Ames, S. C., Parker, A., Crook, J., Diehl, N. N., Tan, W., Williams, C. R. & Ames, G. E., Oct 1 2011, In : Journal of Psychosocial Oncology. 29, 6, p. 593-605 13 p.

Research output: Contribution to journalArticle

Nephrectomy
Renal Cell Carcinoma
Anxiety
Quality of Life
Depression
7 Citations (Scopus)

Treatment of men with rising prostate-specific antigen levels following radical prostatectomy

Tzou, K., Tan, W. & Buskirk, S., Jan 2011, In : Expert Review of Anticancer Therapy. 11, 1, p. 125-136 12 p.

Research output: Contribution to journalArticle

Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms
Recurrence
Therapeutics
2010

Editorial Comment

Tan, W., May 2010, In : Urology. 75, 5, p. 1143 1 p.

Research output: Contribution to journalArticle

Severity of Illness Index
Bone Density Conservation Agents
Imidazoles
Androgen Antagonists
Orchiectomy
28 Citations (Scopus)

Prognosis and outcome of small (≤1 cm), node-negative breast cancer on the basis of hormonal and her-2 status

Amar, S., Mccullough, A. E., Tan, W., Geiger, X. J., Boughey, J. C., McNeil, R. B., Coppola, K. E., Mclaughlin, S. A., Palmieri, F. M. & Perez, E. A., Oct 2010, In : Oncologist. 15, 10, p. 1043-1049 7 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Neoplasms
Recurrence
Adjuvant Chemotherapy
Histology
31 Citations (Scopus)

Update on options for treatment of metastatic castration-resistant prostate cancer

Vishnu, P. & Tan, W., 2010, In : OncoTargets and Therapy. 3, p. 39-51 13 p.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
docetaxel
Prostate-Specific Antigen
Epothilones
2009
9 Citations (Scopus)

N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: A North Central Cancer Treatment Group (NCCTG) Trial

Tan, W., Hillman, D. W., Salim, M., Northfelt, D. W., Anderson, D. M., Stella, P. J., Niedringhaus, R., Bernath, A. M., Gamini, S. S., Palmieri, F. & Perez, E. A., Jul 22 2009, In : Annals of Oncology. 21, 3, p. 493-497 5 p., mdp328.

Research output: Contribution to journalArticle

irinotecan
docetaxel
Breast Neoplasms
Neoplasms
Therapeutics
Urology
Gonadotropin-Releasing Hormone
Testosterone
Prostatic Neoplasms
Prospective Studies
2008
132 Citations (Scopus)

A Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer

Heath, E. I., Hillman, D. W., Vaishampayan, U., Sheng, S., Sarkar, F., Harper, F., Gaskins, M., Pitot, H. C., Tan, W., Ivy, S. P., Pili, R., Carducci, M. A., Erlichman, C. & Liu, G., Dec 1 2008, In : Clinical Cancer Research. 14, 23, p. 7940-7946 7 p.

Research output: Contribution to journalArticle

tanespimycin
Prostatic Neoplasms
Prostate-Specific Antigen
Hormones
Fatigue
51 Citations (Scopus)

Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer

Hines, S. I., Vallow, L. A., Tan, W., McNeil, R. B., Perez, E. A. & Jain, A., 2008, In : Annals of Oncology. 19, 9, p. 1561-1565 5 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Estrogens
Neoplasm Metastasis
Brain
Survival
5 Citations (Scopus)
Ectopic Hormones
Cushing Syndrome
Carcinoid Tumor
Adrenocorticotropic Hormone
Quality of Life